Global Stock News

Bionomics Files Registration Statement for Proposed Initial Public Offering in the United States

Article feature image

Bionomics Files Registration Statement for Proposed Initial Public Offering in the United States

ADELAIDE, Australia, Nov. 23, 2021 /PRNewswire/ — Bionomics Limited (ASX:BNO, OTCQB:BNOEF) (Bionomics or Company), a clinical-stage biopharmaceutical company, today announced the public filing of a registration statement on Form F-1 with the U.S. Securities…

Click here to view the original article.

Share this article

Scroll to Top